Hoya (OTCMKTS:HOCPY) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS
Hoya (OTCMKTS:HOCPY) reported quarterly earnings of $1.10 EPS, exceeding expectations by $0.10. The company generated $1.52 billion in revenue, significantly above the estimated $225.61 billion. Hoya's return on equity was 21.01%, with a net margin of 23.57%. The stock rose to $162.55, with a market cap of $55.77 billion. Analysts have rated Hoya as a "Strong Buy," with recent upgrades from Nomura and Goldman Sachs. Hoya operates in med-tech, offering products in life care, telecommunications, and more.
Hoya (OTCMKTS:HOCPY - Get Free Report) announced its quarterly earnings results on Friday. The technology company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.00 by $0.10, Zacks reports. The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $225.61 billion. Hoya had a return on equity of 21.01% and a net margin of 23.57%.
Hoya Price Performance
HOCPY stock traded up $5.15 on Friday, reaching $162.55. The company had a trading volume of 23,191 shares, compared to its average volume of 19,390. Hoya has a 1 year low of $97.49 and a 1 year high of $164.00. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.46 and a current ratio of 5.19. The company's fifty day moving average is $143.07 and its 200 day moving average is $129.04. The company has a market cap of $55.77 billion, a P/E ratio of 40.64, a PEG ratio of 3.32 and a beta of 1.03.
Wall Street Analyst Weigh In
HOCPY has been the topic of several research analyst reports. Nomura Securities raised Hoya to a "strong-buy" rating in a research note on Monday, August 18th. The Goldman Sachs Group raised Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Three research analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Strong Buy".
View Our Latest Report on Hoya
Hoya Company Profile
(Get Free Report)HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Featured Stories
- Five stocks we like better than Hoya
- Growth Stocks: What They Are, What They Are Not
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- Why Invest in 5G? How to Invest in 5G Stocks
- Super Micro's Moment of Truth: A Growth Story Under Pressure
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Palantir Breaks Out: Why PLTR Stock May Rally Into Year-End
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Hoya Right Now?
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
